Open Journal of Nephrology

Volume 3, Issue 3 (September 2013)

ISSN Print: 2164-2842   ISSN Online: 2164-2869

Google-based Impact Factor: 0.48  Citations  

A Case of Type I Hepatorenal Syndrome Treated with Vasopressin

HTML  Download Download as PDF (Size: 81KB)  PP. 135-138  
DOI: 10.4236/ojneph.2013.33025    7,012 Downloads   9,446 Views  


Hepatorenal syndrome (HRS) is a grave complication of end-stage liver disease and is associated with a very high mortality. This case report described a 42-year-old female with advanced alcohol-induced cirrhosis who developed HRS that was initially treated with Midodrine and Octreotide but renal function continued to deteriorate. Vasopressin therapy was added and HRS was successfully reversed. There are few data available on the use of vasopressin for HRS and this case supports its use in treatment of HRS, particularly in countries where the more widely studied Terlipressin is unavailable. This case also demonstrates that a patient failing one medical therapy for HRS may respond to an alternative or adjunctive therapy. Therefore, this should be attempted to increase the patient’s chance of survival.

Share and Cite:

L. Connor and G. Teehan, "A Case of Type I Hepatorenal Syndrome Treated with Vasopressin," Open Journal of Nephrology, Vol. 3 No. 3, 2013, pp. 135-138. doi: 10.4236/ojneph.2013.33025.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.